{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:24:14Z","timestamp":1793733854811,"version":"4.6.1"},"reference-count":32,"publisher":"Journal of Neurosurgery Publishing Group (JNSPG)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JNS"],"published-print":{"date-parts":[[2014,4]]},"abstract":"<jats:sec>\n<jats:title>Object<\/jats:title>\n<jats:p>Despite improvements in the medical and surgical management of patients with glioblastoma, tumor recurrence remains inevitable. For recurrent glioblastoma, however, the clinical value of a second resection remains uncertain. Specifically, what proportion of contrast-enhancing recurrent glioblastoma tissue must be removed to improve overall survival and what is the neurological cost of incremental resection beyond this threshold?<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>The authors identified 170 consecutive patients with recurrent supratentorial glioblastomas treated at the Barrow Neurological Institute from 2001 to 2011. All patients previously had a de novo glioblastoma and following their initial resection received standard temozolomide and fractionated radiotherapy.<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>The mean clinical follow-up was 22.6 months and no patient was lost to follow-up. At the time of recurrence, the median preoperative tumor volume was 26.1 cm<jats:sup>3<\/jats:sup>. Following re-resection, median postoperative tumor volume was 3.1 cm<jats:sup>3<\/jats:sup>, equating to an 87.4% extent of resection (EOR). The median overall survival was 19.0 months, with a median progression-free survival following re-resection of 5.2 months. Using Cox proportional hazards analysis, the variables of age, Karnofsky Performance Scale (KPS) score, and EOR were predictive of survival following repeat resection (p = 0.0001). Interestingly, a significant survival advantage was noted with as little as 80% EOR. Recursive partitioning analysis validated these findings and provided additional risk stratification at the highest levels of EOR. Overall, at 7 days after surgery, a deterioration in the NIH stroke scale score by 1 point or more was observed in 39.1% of patients with EOR \u2265 80% as compared with 16.7% for those with EOR &lt; 80% (p = 0.0049). This disparity in neurological morbidity, however, did not endure beyond 30 days postoperatively (p = 0.1279).<\/jats:p><\/jats:sec>\n<jats:sec>\n<jats:title>Conclusions<\/jats:title>\n<jats:p>For recurrent glioblastomas, an improvement in overall survival can be attained beyond an 80% EOR. This survival benefit must be balanced against the risk of neurological morbidity, which does increase with more aggressive cytoreduction, but only in the early postoperative period. Interestingly, this putative EOR threshold closely approximates that reported for newly diagnosed glioblastomas, suggesting that for a subset of patients, the survival benefit of microsurgical resection does not diminish despite biological progression.<\/jats:p><\/jats:sec>","DOI":"10.3171\/2013.12.jns13184","type":"journal-article","created":{"date-parts":[[2014,1,31]],"date-time":"2014-01-31T15:05:53Z","timestamp":1391180753000},"page":"846-853","source":"Crossref","is-referenced-by-count":218,"title":["An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity"],"prefix":"10.3171","volume":"120","author":[{"given":"Mark E.","family":"Oppenlander","sequence":"first","affiliation":[{"name":"Division of Neurological Surgery,"},{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Wolf","sequence":"additional","affiliation":[{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Snyder","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"},{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bina","sequence":"additional","affiliation":[{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey R.","family":"Wilson","sequence":"additional","affiliation":[{"name":"Division of Biostatistics, Arizona State University, Tempe, Arizona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen W.","family":"Coons","sequence":"additional","affiliation":[{"name":"Division of Neuropathology, Barrow Neurological Institute, St. Joseph's Hospital and Medical Center, Phoenix; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynn S.","family":"Ashby","sequence":"additional","affiliation":[{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Brachman","sequence":"additional","affiliation":[{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nakaji","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randall W.","family":"Porter","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris A.","family":"Smith","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"},{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert F.","family":"Spetzler","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"},{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Sanai","sequence":"additional","affiliation":[{"name":"Division of Neurological Surgery,"},{"name":"Barrow Brain Tumor Research Center, and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1754","reference":[{"key":"b1-jns13184","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1097\/00006123-199804000-00013","article-title":"Survival and functional status after resection of recurrent glioblastoma multiforme","volume":"42","author":"Barker","year":"1998"},{"key":"b2-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"383","DOI":"10.3171\/jns.1990.72.3.0383","article-title":"Correlation of motor cortex brain mapping data with magnetic resonance imaging","volume":"72","author":"Berger","year":"1990"},{"key":"b3-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.3171\/2012.9.JNS12504","article-title":"Impact of extent of resection for recurrent glioblastoma on overall survival. Clinical article","volume":"117","author":"Bloch","year":"2012"},{"key":"b4-jns13184","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989"},{"key":"b5-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3171\/2012.9.JNS1277","article-title":"Multiple resections for patients with glioblastoma: prolonging survival. Clinical article","volume":"118","author":"Chaichana","year":"2013"},{"key":"b6-jns13184","series-title":"Neuro Oncol","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1093\/neuonc\/nor110","article-title":"Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?","volume":"13","author":"Clarke","year":"2011"},{"key":"b7-jns13184","series-title":"Can J Surg","first-page":"271","article-title":"The value of reoperation for recurrent glioblastoma","volume":"36","author":"Dirks","year":"1993"},{"key":"b8-jns13184","series-title":"The Design and Analysis of Clinical Experiments","author":"Fleiss","year":"1986"},{"key":"b9-jns13184","series-title":"Arch Neurol","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1001\/archneur.1989.00520420080026","article-title":"Interrater reliability of the NIH stroke scale","volume":"46","author":"Goldstein","year":"1989"},{"key":"b10-jns13184","series-title":"Oncol Rep","first-page":"899","article-title":"Is reoperation for recurrence of glioblastoma justified?","volume":"7","author":"Guyotat","year":"2000"},{"key":"b11-jns13184","series-title":"Front Neurol","first-page":"140","article-title":"The value of glioma extent of resection in the modern neurosurgical era","volume":"3","author":"Hardesty","year":"2012"},{"key":"b12-jns13184","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1227\/00006123-198711000-00002","article-title":"Reoperation for recurrent glioblastoma and anaplastic astrocytoma","volume":"21","author":"Harsh","year":"1987"},{"key":"b13-jns13184","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005"},{"key":"b14-jns13184","series-title":"Acta Neurol Scand","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1600-0404.2010.01350.x","article-title":"Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme","volume":"122","author":"Helseth","year":"2010"},{"key":"b15-jns13184","series-title":"J Neurooncol","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1023\/A:1006118018770","article-title":"Extent of resection as a prognostic variable in the treatment of gliomas","volume":"42","author":"Hess","year":"1999"},{"key":"b16-jns13184","series-title":"Radiology","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1148\/radiology.135.2.7367629","article-title":"Computed tomographic localization of the precentral gyrus","volume":"135","author":"Kido","year":"1980"},{"key":"b17-jns13184","series-title":"The Handbook of Psychological Testing","author":"Kline","year":"2000"},{"key":"b18-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3171\/jns.2001.95.2.0190","article-title":"A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival","volume":"95","author":"Lacroix","year":"2001"},{"key":"b19-jns13184","series-title":"Acta Neuropathol","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00401-007-0243-4","article-title":"The 2007 WHO classification of tumours of the central nervous system","volume":"114","author":"Louis","year":"2007"},{"key":"b20-jns13184","series-title":"Surg Neurol","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.surneu.2007.03.043","article-title":"Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy","volume":"69","author":"Mandl","year":"2008"},{"key":"b21-jns13184","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1227\/01.NEU.0000349763.42238.E9","article-title":"Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme","volume":"65","author":"McGirt","year":"2009"},{"key":"b22-jns13184","series-title":"Acta Neurochir (Wien)","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s00701-006-1092-y","article-title":"Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients","volume":"149","author":"Mineo","year":"2007"},{"key":"b23-jns13184","series-title":"Zentralbl Neurochir","first-page":"43","article-title":"Experiences with reoperation on recurrent glioblastoma multiforme","volume":"62","author":"Pinsker","year":"2001"},{"issue":"2","key":"b24-jns13184","series-title":"Neurosurg Focus","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/2009.11.FOCUS09239","article-title":"The reliability of neuroanatomy as a predictor of eloquence: a review","volume":"28","author":"Pouratian","year":"2010"},{"key":"b25-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3171\/2011.2.JNS10998","article-title":"An extent of resection threshold for newly diagnosed glioblastomas. Clinical article","volume":"115","author":"Sanai","year":"2011"},{"key":"b26-jns13184","series-title":"J Neurosurg","doi-asserted-by":"publisher","first-page":"740","DOI":"10.3171\/2011.6.JNS11252","article-title":"Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. Clinical article","volume":"115","author":"Sanai","year":"2011"},{"key":"b27-jns13184","series-title":"Neurosurgery","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1227\/00006123-199604000-00008","article-title":"Functional cortex and subcortical white matter located within gliomas","volume":"38","author":"Skirboll","year":"1996"},{"key":"b28-jns13184","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005"},{"key":"b29-jns13184","series-title":"Int J Med Ed","doi-asserted-by":"publisher","first-page":"53","DOI":"10.5116\/ijme.4dfb.8dfd","article-title":"Making sense of Cronbach's alpha","volume":"2","author":"Tavakol","year":"2011"},{"key":"b30-jns13184","series-title":"J Strength Cond Res","first-page":"231","article-title":"Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM","volume":"19","author":"Weir","year":"2005"},{"key":"b31-jns13184","series-title":"N Engl J Med","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen","year":"2008"},{"key":"b32-jns13184","series-title":"Stroke","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1161\/01.STR.31.4.858","article-title":"Retrospective assessment of initial stroke severity with the NIH Stroke Scale","volume":"31","author":"Williams","year":"2000"}],"container-title":["Journal of Neurosurgery"],"original-title":[],"link":[{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/120\/4\/article-p846.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/120\/4\/article-p846.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/thejns.org\/downloadpdf\/journals\/j-neurosurg\/120\/4\/article-p846.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T13:14:15Z","timestamp":1658668455000},"score":1,"resource":{"primary":{"URL":"https:\/\/thejns.org\/view\/journals\/j-neurosurg\/120\/4\/article-p846.xml"}},"subtitle":["Clinical article"],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":32,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3171\/2013.12.jns13184","relation":{},"ISSN":["0022-3085","1933-0693"],"issn-type":[{"value":"0022-3085","type":"print"},{"value":"1933-0693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}